Global Protein Multiplex Assays Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Protein Multiplex Assays Market Insights, Forecast to 2034
Multiplex protein assays allow multiple targets quantification in a single sample, a bit like performing up to 40 different ELISAs in one go. Outsourcing Multiplex Protein Quantification projects to experts may work out more cost effective and time saving. It saves you the hassle of setting up a new technology in your lab, and you can rely on people with years of expertise in the technology to generate quality data on the very first run. Should you wish to set it up in your own lab, some technologies are easily adaptable if you have access to the equipment.
Market Analysis and InsightsGlobal Protein Multiplex Assays Market
Global Protein Multiplex Assays market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Protein Multiplex Assays industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Protein Multiplex Assays key companies include Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abcam, Becton, Dickinson and Company, Merck KGaA and Agilent Technologies, etc. Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Protein Multiplex Assays were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Protein Multiplex Assays market and estimated to attract more attentions from industry insiders and investors.
Protein Multiplex Assays can be divided into Planar Protein Assays, Bead-Based Protein Assays and Other Protein Assays,, etc. Planar Protein Assays is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Protein Multiplex Assays is widely used in various fields, such as Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Other End Users, etc. Pharmaceutical & Biotechnology Companies provides greatest supports to the Protein Multiplex Assays industry development. In 2022, global % revenue of Protein Multiplex Assays went into Pharmaceutical & Biotechnology Companies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Protein Multiplex Assays market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Protein Multiplex Assays market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Segment by Type
Planar Protein Assays
Bead-Based Protein Assays
Other Protein Assays
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Protein Multiplex Assays introduction, etc. Protein Multiplex Assays Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Protein Multiplex Assays
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Protein Multiplex Assays Market
Global Protein Multiplex Assays market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Protein Multiplex Assays industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Protein Multiplex Assays key companies include Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abcam, Becton, Dickinson and Company, Merck KGaA and Agilent Technologies, etc. Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Protein Multiplex Assays were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Protein Multiplex Assays market and estimated to attract more attentions from industry insiders and investors.
Protein Multiplex Assays can be divided into Planar Protein Assays, Bead-Based Protein Assays and Other Protein Assays,, etc. Planar Protein Assays is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Protein Multiplex Assays is widely used in various fields, such as Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Other End Users, etc. Pharmaceutical & Biotechnology Companies provides greatest supports to the Protein Multiplex Assays industry development. In 2022, global % revenue of Protein Multiplex Assays went into Pharmaceutical & Biotechnology Companies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Protein Multiplex Assays market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Protein Multiplex Assays market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Segment by Type
Planar Protein Assays
Bead-Based Protein Assays
Other Protein Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Protein Multiplex Assays introduction, etc. Protein Multiplex Assays Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Protein Multiplex Assays
Chapter 13Methodology and Data Sources adopted by MRAResearch